Rekombinanter Myosin 9 Antikörper (Atto 488)
-
- Target Alle Myosin 9 (MYH9) Antikörper anzeigen
- Myosin 9 (MYH9)
- Antikörpertyp
- Recombinant Antibody
-
Reaktivität
- Human, Maus, Ratte, Drosophila melanogaster
-
Wirt
-
Human
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Myosin 9 Antikörper ist konjugiert mit Atto 488
-
Applikation
- Immunocytochemistry (ICC)
- Spezifität
- Recognizes human, mouse, rat and drosophila myosin IIA (heavy chain).
- Kreuzreaktivität
- Fruchtfliege (Drosophila melanogaster), Human, Maus, Ratte (Rattus)
- Reinheit
- >95 % (SDS-PAGE)
- Immunogen
- Full length myosin IIA from rat liver.
- Klon
- SF9
- Isotyp
- IgG2
- Top Product
- Discover our top product MYH9 Primärantikörper
-
-
- Kommentare
-
anti-Myosin IIA (non-muscle), monoclonal antibody (recombinant) (SF9) (ATTO 488) is composed of human variable regions (VH and VL) (lambda-chain) of immunoglobulin fused to the human lgG2 Fc domain and labeled with ATTO 488.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- In PBS containing 10 % glycerol and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Informationen zur Lagerung
-
Short Term Storage: +4°C
Long Term Storage: +4°C
Keep conjugated formats at +4°C.
-
- Target
- Myosin 9 (MYH9)
- Andere Bezeichnung
- Myosin IIA (MYH9 Produkte)
- Synonyme
- BDPLT6 antikoerper, DFNA17 antikoerper, EPSTS antikoerper, FTNS antikoerper, MHA antikoerper, NMHC-II-A antikoerper, NMMHC-IIA antikoerper, NMMHCA antikoerper, C80049 antikoerper, D0Jmb2 antikoerper, E030044M24Rik antikoerper, Fltn antikoerper, Myhn-1 antikoerper, Myhn1 antikoerper, NMHC II-A antikoerper, NMHCIIA antikoerper, NMMHC II-a antikoerper, NMMHC-A antikoerper, TU72.6 antikoerper, fi22c04 antikoerper, myh9 antikoerper, myh9l2 antikoerper, wu:fi22c04 antikoerper, wu:fj85e11 antikoerper, zgc:162029 antikoerper, zgc:66164 antikoerper, NMMHC antikoerper, myosin antikoerper, non-muscle antikoerper, nonmuscle antikoerper, KLG/PTK7 antikoerper, dfna17 antikoerper, epsts antikoerper, ftns antikoerper, nmhc-ii-a antikoerper, nmmhca antikoerper, myosin heavy chain 9 antikoerper, myosin, heavy polypeptide 9, non-muscle antikoerper, myosin, heavy chain 9a, non-muscle antikoerper, myosin, heavy chain 9, non-muscle antikoerper, myosin, heavy chain 9, non-muscle L homeolog antikoerper, MYH9 antikoerper, Myh9 antikoerper, myh9a antikoerper, myh9.L antikoerper
- Hintergrund
- Anti-Myosin IIA (non-muscle), monoclonal antibody (recombinant) (SF9) is an antibody developed by antibody phage display technology using a human naive antibody gene library. These libraries consist of scFv (single chain fragment variable) composed of VH (variable domain of the human immunoglobulin heavy chain) and VL (variable domain of the human immunoglobulin light chain) connected by a polypeptide linker. The antibody fragments are displayed on the surface of filamentous bacteriophage (M13). This scFv was selected by affinity selection on antigen in a process termed panning. Multiple rounds of panning are performed to enrich for antigen-specific scFv-phage. Monoclonal antibodies are subsequently identified by screening after each round of selection. The selected monoclonal scFv is cloned into an appropriate vector containing a Fc portion of interest and then produced in mammalian cells to generate an IgG like scFv-Fc fusion protein.
- UniProt
- P35579
- Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling, Integrin Complex
-